Skip to main content
Premium Trial:

Request an Annual Quote

Richard Taylor Joins Vermillion

Premium
Vermillion appointed Richard Taylor senior finance consultant and interim chief financial officer last month.
 
He takes over as interim CFO from Qun Zhou, who had held the post since Nov. 1, 2007. The consulting agreement between Taylor and Vermillion is for 90 days and may be extended upon mutual agreement.
 
Prior to joining Vermillion, Taylor was head of finance for US operations at Progen Pharmaceuticals. Between 2001 and February of 2008, Taylor was vice president of finance and administration at Cellgate before it was acquired by Progen.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.